Latest news
Standard BioTools Sells Mass Cytometry Business and Secures $30 Million Illumina Buyout Ahead of Treeline Merger - citybizcitybiz · Tue, 28 Jul 2026 12:32:40 GMTStandard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences - SahmSahm · Tue, 28 Jul 2026 07:00:00 GMT